21st Century Cures Act
Monday, February 6, 2017
The 21st Century Cures Act provides funding for the National Institutes of Health (NIH) to the tune of $4.8 billion. The Act also provides key provisions for other areas of health research.
NIH Initiatives
- 10 years of funding for the cancer “moonshot,” the BRAIN initiative and the Precision Medicine Initiative
Help for HME
- Delays competitive bid derived pricing for complex rehab technology (CRT) accessories used with Group 3 power wheelchairs until July 1, 2017
- Extends the transition period for the second part of the bidding-derived cuts from June 30, 2016 to December 31, 2016, paving the way for HME suppliers to recoup reductions for items with dates of service from July 1 to the end of 2016. The second phase of the cuts that had originally gone into effect on July 1, 2016 would again go into effect on January 1, 2017
- Instructs the Department of Health & Human Services (HHS) to conduct a study on the impact of the bidding program on the overall number of HME providers and availability of HME products over the course of 2016
FDA Regulations
- $500 million in funding to expand staffing and speed up processing
- Directs FDA to include real-world evidence in considering new indications for approved drugs (e.g. a seizure drug used as a migraine preventative)
- Fast-tracks drug approval process in most cases
- The bill also includes provisions and funding to improve mental health care and suicide prevention, as well as $1 billion in grants to the states to fight the opioid epidemic